Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Safety and Efficacy of Intravenous Administration of SHED-CM for ALS [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluates the safety and potential efficacy of intravenous SHED-CM for amyotrophic lateral sclerosis, sponsored by Hitonowa Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHED-CM

Snippet

Sponsor: Hitonowa Medical | Conditions: Amyotrophic Lateral Sclerosis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING